Resistance to prostate-cancer treatment is driven by immune cells

Matthew D. Galsky ()

Nature, 2018, vol. 559, issue 7714, 338-339

Abstract: Prostate-cancer treatment usually fails after time as resistance to therapy develops. It emerges from studies of mice and human cells that a population of immune cells can cause this type of treatment resistance.

Keywords: Cancer; Medical research (search for similar items in EconPapers)
Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-018-05460-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:559:y:2018:i:7714:d:10.1038_d41586-018-05460-y

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-018-05460-y

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().